Contributors
Lea Beier:
ORCID: https://orcid.org/0000-0003-1861-0635
Role: ConceptualizationRole: Writing – original draftRole: Writing – review & editing
Shihai Lu: Role: Data curationRole: Formal analysisRole: ValidationRole: Writing – review & editing
Lionel Riou França: Role: Data curationRole: Formal analysisRole: ValidationRole: Writing – review & editing
Sabrina Marler: Role: Data curationRole: Formal analysisRole: ValidationRole: Writing – review & editing
Gregory Y. H. Lip: Role: ConceptualizationRole: MethodologyRole: Writing – original draftRole: Writing
– review & editing
Menno V. Huisman: Role: ConceptualizationRole: InvestigationRole: MethodologyRole: Writing – original
draftRole: Writing – review & editing
Christine Teutsch: Role: ConceptualizationRole: Formal analysisRole: Funding acquisitionRole: MethodologyRole:
Writing – original draftRole: Writing – review & editing
Jonathan L. Halperin: Role: MethodologyRole: Writing – original draft
Kristina Zint: Role: Writing – review & editing
Hans-Christoph Diener: Role: MethodologyRole: Writing – review & editing
Laurie Baker: Role: Writing – review & editing
Chang-Sheng Ma: Role: Writing – review & editing
Miney Paquette: Role: Writing – review & editing
Dorothee B. Bartels: Role: Writing – review & editing
Sergio J. Dubner:
ORCID: https://orcid.org/0000-0001-9449-9225
Role: Writing – review & editing
Philippe Lyrer: Role: Writing – review & editing
Jochen Senges: Role: Writing – review & editing
Kenneth J. Rothman: Role: Writing – review & editing
Giuseppe Andò: Role: Editor
Journal
Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS One
Journal ID (publisher-id): plos
Title:
PLoS ONE
Publisher:
Public Library of Science
(San Francisco, CA USA
)
ISSN
(Electronic):
1932-6203
Publication date
(Electronic):
6
October
2022
Publication date Collection: 2022
Volume: 17
Issue: 10
Electronic Location Identifier: e0274237
Affiliations
[1
]
Charité–Universitätsmedizin Berlin, Berlin, Germany
[2
]
Takeda Pharmaceuticals, Inc., Cambridge, Massachusetts, United States of America
[3
]
Sanofi-Aventis Recherche et Développement, Chilly-Mazarin, France
[4
]
Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool
Heart & Chest Hospital, Liverpool, United Kingdom
[5
]
Department of Clinical Medicine, Aalborg Thrombosis Research Unit, Aalborg University,
Aalborg, Denmark
[6
]
Leiden University Medical Center, Leiden, the Netherlands
[7
]
Department of CardioMetabolism and Respiratory Medicine, Boehringer Ingelheim International
GmbH, Ingelheim, Germany
[8
]
Icahn School of Medicine at Mount Sinai, New York City, New York, United States of
America
[9
]
University Hospital Essen, Essen, Germany
[10
]
Boehringer Ingelheim, Burlington, Canada
[11
]
Atrial Fibrillation Center, Beijing Anzhen Hospital, Beijing, People’s Republic of
China
[12
]
Hannover Medical School, Hannover, Germany
[13
]
UCB Biosciences GmbH, Monheim, Germany
[14
]
Clínica y Maternidad Suizo Argentina, Buenos Aires, Argentina
[15
]
University Hospital Basel, Stroke Center Neurology, and University of Basel, Basel,
Switzerland
[16
]
Stiftung Institut, Ludwigshafen, Germany
[17
]
RTI Health Solutions, Research Triangle Institute, Research Triangle Park, North Carolina,
United States of America
University of Messina, ITALY
Author notes
Competing Interests: L Beier declares no conflicts of interest at the time of manuscript writing and is
now an employee of Novartis Pharma GmbH. S Lu was an employee of Boehringer Ingelheim
at the time of manuscript writing and is now employed by Biogen Inc. S Marler, C Teutsch,
K Zint, L Baker and M Paquette are employees of Boehringer Ingelheim. L Riou França
was an employee of Boehringer Ingelheim at the time of manuscript writing and is now
employed by Sanofi-Aventis. GYH Lip is a consultant and speaker for BMS/Pfizer, Boehringer
Ingelheim and Daiichi-Sankyo. No fees are received personally. MV Huisman reports
grants from ZonMW Dutch Healthcare Fund, grants and fees to the hospital from Boehringer
Ingelheim, Pfizer-BMS, Bayer HealthCare, Aspen, Daiichi-Sankyo, outside the submitted
work. JL Halperin has engaged in consulting activities with Boehringer Ingelheim,
for advisory activities involving anticoagulants, and he is a member of the Executive
Steering Committee of the GLORIA-AF Registry. H-C Diener has received honoraria for
participation in clinical trials, contribution to advisory boards or oral presentations
from: Abbott, Bayer Vital, Bristol-Myers Squibb (BMS), Boehringer Ingelheim, Daiichi-Sankyo,
Medtronic, Pfizer, Portola, Sanofi-Aventis, and WebMD Global. Financial support for
research projects was provided by Boehringer Ingelheim. Dr Diener chairs the Treatment
Guidelines Committee of the German Society of Neurology and contributed to the EHRA
and ESC guidelines for the treatment of AF. C-S Ma has received honoraria for lectures
from AstraZeneca, Bayer HealthCare, Boehringer Ingelheim, BMS, Johnson & Johnson,
and Pfizer. DB Bartels was an employee of Boehringer Ingelheim at time of manuscript
writing and is now an employee at UCB Pharma GmbH. SJ Dubner has received consultancy
fees for serving as a steering committee member for Boehringer Ingelheim; he also
holds research grants from St Jude Medical. P Lyrer has received honoraria for contribution
to advisory boards from Boehringer Ingelheim, BMS, Bayer, Pfizer, Daiichi Sankyo,
and Ricordati, and research grants from the Swiss Heart Foundation, Swiss National
Foundation, Bayer, Sanofi, Acticor, and the University Hospital Basel foundation (propatient).
J Senges has received honoraria for contribution to advisory boards from Boehringer
Ingelheim. KJ Rothman declares no conflicts of interest.
‡ MVH and GYHL are co-Chairs of the GLORIA-AF registry program and are joint senior
authors with KJR.
Author information
Article
Publisher ID:
PONE-D-21-27023
DOI: 10.1371/journal.pone.0274237
PMC ID: 9536607
PubMed ID: 36201473
SO-VID: b166b0cc-2dc9-4351-a77b-e44a3b2aef87
Copyright © © 2022 Beier et al
License:
This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided
the original author and source are credited.
History
Date
received
: 26
August
2021
Date
accepted
: 16
August
2022
Page count
Figures: 4,
Tables: 2,
Pages: 14
Funding
Funded by:
funder-id http://dx.doi.org/10.13039/100008349, Boehringer Ingelheim;
Award Recipient
:
ORCID: https://orcid.org/0000-0003-1861-0635
Lea Beier
This registry program was funded by Boehringer Ingelheim GmbH. Boehringer Ingelheim
were involved in the study design, data collection and analysis, preparation of the
manuscript and review for scientific accuracy. Authors had the final decision on content
and the decision to publish; specific roles of each author are articulated in the
“author contributions” section.
Categories
Subject:
Research Article
Subject:
Medicine and Health Sciences
Subject:
Epidemiology
Subject:
Medical Risk Factors
Subject:
Medicine and Health Sciences
Subject:
Cardiology
Subject:
Arrhythmia
Subject:
Atrial Fibrillation
Subject:
Medicine and Health Sciences
Subject:
Medical Conditions
Subject:
Cardiovascular Diseases
Subject:
Cardiovascular Disease Risk
Subject:
Medicine and Health Sciences
Subject:
Cardiology
Subject:
Cardiovascular Medicine
Subject:
Cardiovascular Diseases
Subject:
Cardiovascular Disease Risk
Subject:
Medicine and Health Sciences
Subject:
Pharmaceutics
Subject:
Drug Therapy
Subject:
Antiplatelet Therapy
Subject:
Medicine and Health Sciences
Subject:
Medical Conditions
Subject:
Cerebrovascular Diseases
Subject:
Stroke
Subject:
Ischemic Stroke
Subject:
Medicine and Health Sciences
Subject:
Neurology
Subject:
Cerebrovascular Diseases
Subject:
Stroke
Subject:
Ischemic Stroke
Subject:
Medicine and Health Sciences
Subject:
Vascular Medicine
Subject:
Stroke
Subject:
Ischemic Stroke
Subject:
Medicine and Health Sciences
Subject:
Clinical Medicine
Subject:
Signs and Symptoms
Subject:
Hemorrhage
Subject:
Medicine and Health Sciences
Subject:
Vascular Medicine
Subject:
Hemorrhage
Subject:
Medicine and Health Sciences
Subject:
Pharmaceutics
Subject:
Drug Therapy
Subject:
Antiplatelet Therapy
Subject:
Oral Antiplatelet Therapy
Subject:
Medicine and Health Sciences
Subject:
Pharmaceutics
Subject:
Drug Therapy
Subject:
Cardiovascular Therapy
Subject:
Anticoagulant Therapy
Custom metadata
